Effects of various media on the activity of NXL103 (formerly XRP 2868), a new oral streptogramin, against Haemophilus influenzae - Wikidata - wikimedia - TriplyDB

Effects of various media on the activity of NXL103 (formerly XRP 2868), a new oral streptogramin, against Haemophilus influenzae

Effects of various media on the activity of NXL103 (formerly XRP 2868), a new oral streptogramin, against Haemophilus influenzae

http://www.wikidata.org/entity/Q24675058

about

NXL-103, a combination of flopristin and linopristin, for the potential treatment of bacterial infections including community-acquired pneumonia and MRSA.

P2860

Q30433276-31EDB82A-74A0-4219-8F96-ACB19E5E6FD7

P2860

Effects of various media on the activity of NXL103 (formerly XRP 2868), a new oral streptogramin, against Haemophilus influenzae

http://www.wikidata.org/entity/Q24675058

description

2006 nî lūn-bûn

@nan

2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Effects of various media on th ...... against Haemophilus influenzae

@ast

Effects of various media on th ...... against Haemophilus influenzae

@en

Effects of various media on th ...... against Haemophilus influenzae

@nl

type

label

Effects of various media on th ...... against Haemophilus influenzae

@ast

Effects of various media on th ...... against Haemophilus influenzae

@en

Effects of various media on th ...... against Haemophilus influenzae

@nl

prefLabel

Effects of various media on th ...... against Haemophilus influenzae

@ast

Effects of various media on th ...... against Haemophilus influenzae

@en

Effects of various media on th ...... against Haemophilus influenzae

@nl

P1433

Q24675058-E05FCDA8-DB13-47DF-8548-2E7FCD8586C0

P1476

Q24675058-C9CE66AD-CD14-4BF4-9C34-B6B87EA62BCC

P2093

Q24675058-01194F1E-CCF0-4231-B6F6-33925C43F141

Q24675058-40DCD76C-C2D3-46D2-97A2-377B8471459E

Q24675058-BB443CCD-C5AC-4D79-9042-F056C2738B10

Q24675058-D49D994D-E3EE-4B2C-9917-24E6B64EAD26

Q24675058-E21AE9A5-1BF7-48F1-8326-F958BDAEFC0E

P2860

Q24675058-025F9B12-749B-43A7-9D64-DE9F6013D1A0

Q24675058-2180BDFE-7CF3-40FA-AB89-BE598EFC5597

Q24675058-666CCFBE-C66B-4829-AF71-1F17C5AB53EA

Q24675058-7FC8A193-6BED-4CF6-9EA7-BEA5E4852EA4

Q24675058-89414E0F-3974-4C6B-95AD-42095112CDDC

Q24675058-AA44F971-2A32-4E37-9055-A50F17FC9806

Q24675058-B08E2374-006F-493C-B00E-E07942F2CD90

Q24675058-E5B42153-9C26-4B63-828B-B84C01371580

P304

Q24675058-FD505C47-825C-4F92-A079-79C7AE6FD622

P31

Q24675058-172FD921-9A88-41C2-AA8E-07299D4C748D

P356

Q24675058-BDADF7FF-5356-4845-BADA-897D8EDF8984

P407

Q24675058-6BC47100-2F8E-45AE-A939-8CFE2A51AEB2

P433

Q24675058-5B587D13-9B84-4508-9263-07312B330EC5

P478

Q24675058-9431017E-F84F-4167-9C0C-1F53FAFC530A

P577

Q24675058-A3C80333-BE41-4B26-885F-8FC9FD3E8F31

P698

Q24675058-F08875A8-FD48-456F-8C49-14012CC9D64B

P932

Q24675058-7B99315A-4ABE-4B41-8C79-5FE838AAFFA6

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Effects of various media on th ...... against Haemophilus influenzae

@en

P2093

André Bryskier

http://www.w3.org/2001/XMLSchema#string

Dianne Hoellman

http://www.w3.org/2001/XMLSchema#string

Glenn A Pankuch

http://www.w3.org/2001/XMLSchema#string

John Lowther

http://www.w3.org/2001/XMLSchema#string

Peter C Appelbaum

http://www.w3.org/2001/XMLSchema#string

P2860

Activities of a new oral streptogramin, XRP 2868, compared to those of other agents against Streptococcus pneumoniae and haemophilus species

Comparative in vitro activities of XRP 2868, pristinamycin, quinupristin-dalfopristin, vancomycin, daptomycin, linezolid, clarithromycin, telithromycin, clindamycin, and ampicillin against anaerobic gram-positive species, actinomycetes, and lactobac

Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children

Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters.

Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates

Contribution of beta-lactamase and PBP amino acid substitutions to amoxicillin/clavulanate resistance in beta-lactamase-positive, amoxicillin/clavulanate-resistant Haemophilus influenzae.

Inability of L22 ribosomal protein alteration to increase macrolide MICs in the absence of efflux mechanism in Haemophilus influenzae HMC-S.

Susceptibility of European beta-lactamase-positive and -negative Haemophilus influenzae isolates from the periods 1997/1998 and 2002/2003.

P304

3914-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00587-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2006-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17065630

http://www.w3.org/2001/XMLSchema#string

P932

1635171

http://www.w3.org/2001/XMLSchema#string